This is a working overview of Quality control, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-05-11 and is reviewed periodically as new material appears.
Nicotinamide mononucleotide, usually shortened to NMN, is a naturally occurring nucleotide. Its structure consists of a nicotinamide base linked to a ribose sugar that carries a phosphate group. In cells, NMN serves as an intermediate in the salvage pathway that produces nicotinamide adenine dinucleotide, or NAD+. Because NAD+ participates in many oxidation-reduction reactions, NMN sits near central metabolic processes. The compound is not a drug in most jurisdictions and is discussed mainly in biochemistry and nutrition research.
The term NMN commonly refers to the beta isomer, in which the nicotinamide group is attached to the ribose through a beta-glycosidic bond. Commercial material may be supplied as the free acid or as a salt, such as a sodium salt, which affects molecular weight and water solubility. Related compounds include nicotinamide riboside and NAD+ itself, but these are distinct molecules with different formulas and cellular handling. Laboratory research often uses the beta form because it matches the naturally occurring configuration found in biological systems.
Analytical measurement of NMN typically uses reversed-phase high-performance liquid chromatography with ultraviolet detection near 260 nm. Mass spectrometry, often coupled to liquid chromatography, provides sensitive quantification and confirmatory identification in biological matrices. Nuclear magnetic resonance spectroscopy is used to verify molecular structure and distinguish related nucleotides. Because NMN is polar and poorly retained on conventional reversed-phase columns, ion-pairing reagents or hydrophilic interaction chromatography are sometimes employed. Reported purity values depend on the chosen method, calibration standard, and whether related substances are resolved.
Stability studies indicate that NMN is sensitive to heat, light, and pH extremes. In aqueous solution, hydrolysis can cleave the phosphate linkage or convert NMN to related nicotinamide derivatives, with degradation accelerating at elevated temperatures and alkaline conditions. Solid material is generally more stable when kept dry and cold, and research-grade supplies are often stored at minus twenty degrees Celsius or lower, protected from light and moisture. Repeated freeze-thaw cycles of solutions can promote degradation, so aliquoting is a common laboratory practice. The exact shelf life depends on purity, counterion, packaging, and storage history.
| Property | Value | Notes |
|---|---|---|
| Chemical name | beta-Nicotinamide mononucleotide | Free acid and salt forms share the core structure. |
| Molecular formula | C11H15N2O8P | Calculated for the free acid; salt forms add counterions. |
| Molar mass | 334.22 g/mol | Approximate value for the free acid form. |
| Appearance | White to off-white powder | Color and texture can vary with purity and salt form. |
| Solubility | Water-soluble | Typically soluble in aqueous media; less soluble in nonpolar solvents. |
Nicotinamide mononucleotide, commonly abbreviated NMN, is a naturally occurring nucleotide found in the cells of many organisms. Its structure consists of a nicotinamide group linked to a ribose sugar that carries a phosphate group. NMN is an intermediate in the biosynthesis of nicotinamide adenine dinucleotide, or NAD+, a coenzyme involved in many metabolic reactions. The abbreviation usually refers to the beta anomer, though related forms can exist. In scientific literature, NMN is distinct from nicotinamide riboside, another NAD+ precursor.
In the NAD+ salvage pathway, the enzyme NAMPT converts nicotinamide and a phosphate-donor molecule into NMN. A second enzyme, NMNAT, then converts NMN into NAD+. Nicotinamide riboside can also enter this route after being converted to NMN by nicotinamide riboside kinases. Because NMN sits at a junction between precursor uptake and NAD+ formation, its cellular concentration is tightly linked to enzyme activity and tissue type. NAD+ participates in redox reactions, signaling, and DNA repair, and its levels decline with age in some animal models, though human evidence remains more limited and context-dependent.
Stability of NMN depends on physical form, temperature, moisture, light, and pH. The solid compound is generally more stable than aqueous solutions, which can degrade over time, especially when warm or exposed to extreme pH. Recommended laboratory storage is typically desiccated at −20 °C or below, protected from light, with containers sealed to limit moisture uptake. In solution, degradation products may include nicotinamide and related ribosides, and the rate varies with buffer composition and concentration. Analytical laboratories often prepare fresh solutions and validate stability for each method.
Quality control for NMN materials usually covers identity, assay purity, residual solvents, heavy metals, microbial limits, and moisture content. Certificates of analysis from suppliers may report high-performance liquid chromatography purity, mass spectrometry identity, and elemental impurity testing. Regulatory treatment differs by country: NMN is not an approved drug, and its status as a dietary supplement ingredient or novel food has been debated. Some authorities have restricted sales pending safety and regulatory review, while others allow it under specific categories. Buyers should verify documentation rather than rely on label claims.
== Active site == The active site of the second structure has 2 tunnels, one with a radius of 1.21 Å and one with a radius of 1.19 Å. The 1.21 Å tunnel has a length of 26.7 Å and the 1.19 Å tunnel has a length of 27.5 Å. The active site of the first version has one tunnel that has a radius of 1.14 Å and a length of 26.0 Å. As with the structures, these parts of the enzyme can be examined further using the links in the caption.
=== Industrial applications === Casein proteins, which are about 80% of the proteins in cow milk and between 20% and 60% in human milk. Xylanases, enzymes which degrade the linear polysaccharide xylan into xylose, thus breaking down hemicellulose, one of the major components of plant cell walls Proteases, an enzyme which catalyze proteolysis, breaking down proteins into smaller polypeptides or single amino acids. They have found applications in both the industrial (such as the food industry). and domestic settings. Whey proteins, which are about 20% of the proteins in cow milk and 60% in human milk.
One of the SERRS was a "targeted nanoprobe functionalized with an anti-folate-receptor antibody (αFR-Ab) via a PEG-maleimide-succinimide and using the infrared dye IR780 as the Raman reporter, henceforth referred to as αFR-NP, and a nontargeted probe (nt-NP) coated with PEG5000-maleimide and featuring the IR140 infrared dye as the Raman reporter." These two different mixtures were injected into tumor bearing mice and healthy controlled mice. The mice were imaged with Bioluminescence (BLI) signal that produces light energy within an organism's body. They were also scanned with the Raman microscope in order to be able to see the correlation between the TAS3RS and the BLI map. TAS3RS did not show anything in the healthy mice, but was able to locate the tumor lesions in the infected mice and also able to create a TAS3RS map that could be used as guidance during surgery. TAS3RS shows to be promising in being able to combat ovarian and peritoneal cancer as it allows early detection with high accuracy. This technique can be administered locally, which is an advantage as it does not have to enter the bloodstream and therefore bypassing the toxicity concerns circulating nanoprobes. This technique is also more photostable than fluorochromes because SERRS nanoparticles cannot form from biomolecules and therefore there would not be any false positives in TAS3RS as there is in fluorescence imaging.
Sources: en.wikipedia.org
=== Early life === Frederik Dag Arfst Paulsen was born on 30 October 1950 in Stockholm, Sweden, as a Swedish citizen. His father was Frederik Paulsen Sr, the founder of Ferring Pharmaceuticals. Paulsen grew up in Sweden, with his father and his father's second wife, Dr. Eva Wolf Frandsen – one of the founding researchers at Ferring. He attended school in Sweden and then went on to study chemistry at the Christian Albrecht University in Kiel, (Germany) and business administration at Lund University in Sweden. He received his doctoral degree in Demography from Ecole des Hautes Etudes en Sciences Sociales in Paris, France.
== Hormonal regulation == Insulin is a peptide hormone that is critical for managing the body's metabolism. Insulin is released by the pancreas when blood sugar levels rise, and it has many effects that broadly promote the absorption and storage of sugars, including lipogenesis. Insulin stimulates lipogenesis primarily by activating two enzymatic pathways. Pyruvate dehydrogenase (PDH), converts pyruvate into acetyl-CoA. Acetyl-CoA carboxylase (ACC), converts acetyl-CoA produced by PDH into malonyl-CoA. Malonyl-CoA provides the two-carbon building blocks that are used to create larger fatty acids. Insulin stimulation of lipogenesis also occurs through the promotion of glucose uptake by adipose tissue. The increase in the uptake of glucose can occur through the use of glucose transporters directed to the plasma membrane or through the activation of lipogenic and glycolytic enzymes via covalent modification. The hormone has also been found to have long term effects on lipogenic gene expression. It is hypothesized that this effect occurs through the transcription factor SREBP-1, where the association of insulin and SREBP-1 lead to the gene expression of glucokinase. The interaction of glucose and lipogenic gene expression is assumed to be managed by the increasing concentration of an unknown glucose metabolite through the activity of glucokinase. Another hormone that may affect lipogenesis through the SREBP-1 pathway is leptin. It is involved in the process by limiting fat storage through inhibition of glucose intake and interfering with other adipose metabolic pathways.
Physically speaking, tea has properties of both a solution and a suspension. It is a solution of the water-soluble compounds extracted from the tea leaves, such as the polyphenols and amino acids. Tea infusions are among most consumed beverages globally. Caffeine makes up about 3% of tea's dry weight, which translates to between 30 and 90 milligrams per 250-millilitre (8+1⁄2 US fl oz) cup depending on the type, brand, and brewing method. A study found that the caffeine content of one gram of black tea ranged from 22 to 28 mg, while the caffeine content of one gram of green tea ranged from 11 to 20 mg, reflecting a significant difference. Tea contains small amounts of theobromine and theophylline, which are xanthines and stimulants, similar to caffeine.
Sources: en.wikipedia.org
==== MeSH D06.472.334 – gonadal hormones ==== MeSH D06.472.334.500 – activins MeSH D06.472.334.500.500 – inhibin-beta subunits MeSH D06.472.334.734 – corpus luteum hormones MeSH D06.472.334.734.623 – progesterone MeSH D06.472.334.734.769 – relaxin MeSH D06.472.334.851 – gonadal steroid hormones MeSH D06.472.334.851.437 – estradiol congeners MeSH D06.472.334.851.437.249 – equilenin MeSH D06.472.334.851.437.374 – equilin MeSH D06.472.334.851.437.500 – estradiol MeSH D06.472.334.851.437.750 – estriol MeSH D06.472.334.851.437.750.320 – estetrol MeSH D06.472.334.851.437.968 – estrogenic steroids, alkylated MeSH D06.472.334.851.437.968.500 – ethinyl estradiol MeSH D06.472.334.851.437.968.500.250 – ethinyl estradiol-norgestrel combination MeSH D06.472.334.851.437.968.500.500 – mestranol MeSH D06.472.334.851.437.968.500.750 – quinestrol MeSH D06.472.334.851.437.984 – estrogens, catechol MeSH D06.472.334.851.437.984.350 – hydroxyestrones MeSH D06.472.334.851.437.988 – estrogens, conjugated (usp) MeSH D06.472.334.851.437.994 – estrogens, esterified (usp) MeSH D06.472.334.851.437.996 – estrone MeSH D06.472.334.851.687 – progesterone congeners MeSH D06.472.334.851.687.500 – pregnenolone MeSH D06.472.334.851.687.500.500 – 17-alpha-hydroxypregnenolone MeSH D06.472.334.851.687.750 – progesterone MeSH D06.472.334.851.687.750.074 – 20-alpha-dihydroprogesterone MeSH D06.472.334.851.687.750.099 – 5-alpha-dihydroprogesterone MeSH D06.472.334.851.687.750.478 – hydroxyprogesterones MeSH D06.472.334.851.687.750.478.400 – 17-alpha-hydroxyprogesterone MeSH D06.472.334.851.687.750.478.400.500 – pregnanetriol MeSH D06.472.334.851.687.750.739 – pregnanediol MeSH D06.472.334.851.968 – testosterone congeners MeSH D06.472.334.851.968.500 – androstane-3,17-diol MeSH D06.472.334.851.968.750 – androstenediol MeSH D06.472.334.851.968.875 – androstenedione MeSH D06.472.334.851.968.937 – androsterone MeSH D06.472.334.851.968.952 – dehydroepiandrosterone MeSH D06.472.334.851.968.952.300 – dehydroepiandrosterone sulfate MeSH D06.472.334.851.968.964 – dihydrotestosterone MeSH D06.472.334.851.968.968 – etiocholanolone MeSH D06.472.334.851.968.976 – nandrolone MeSH D06.472.334.851.968.984 – testosterone MeSH D06.472.334.851.968.984.500 – epitestosterone MeSH D06.472.334.851.968.984.750 – testosterone propionate MeSH D06.472.334.968 – inhibins MeSH D06.472.334.968.500 – inhibin-beta subunits MeSH D06.472.334.984 – testicular hormones
== Activism, research centers == The Center for Orphan Drug Research at the University of Minnesota College of Pharmacy helps small companies with insufficient in-house expertise and resources in drug synthesis, formulation, pharmacometrics, and bio-analysis. The Keck Graduate Institute Center for Rare Disease Therapies (CRDT) in Claremont, California, supports projects to revive potential orphan drugs whose development has stalled by identifying barriers to commercialization, such as problems with formulation and bio-processing. Numerous advocacy groups such as the National Organization for Rare Disorders, Global Genes Project, Children's Rare Disease Network, Abetalipoproteinemia Collaboration Foundation, Zellweger Baby Support Network, and the Friedreich's Ataxia Research Alliance have been founded in order to advocate on behalf of patients with rare diseases with a particular emphasis on diseases that affect children.
As larger doses of these pharmaceuticals are administered the plasma concentrations of the unmetabolized drug increases and the elimination half-life increases. It is therefore necessary to adjust the dose or other treatment parameters when a high dosage is required. The kidneys can also establish active elimination mechanisms for some drugs, independent of plasma concentrations. It can therefore be seen that non-linearity can occur because of reasons that affect the entire pharmacokinetic sequence: absorption, distribution, metabolism and elimination.
== Efficacy == On 16 June 2021, CureVac said its vaccine showed 47% efficacy from its Phase IIb/III trial. Later, the final result data showed an efficacy of 48% against symptomatic disease in all age groups and, for people aged 18 to 60 years, an efficacy of 53% against symptomatic disease, 77% against moderate and severe disease and 100% against hospitalization and death, as no cases were detected in the study. This was based on interim analysis of 134 COVID cases in its Phase III study conducted in Europe and Latin America. The final analysis for the trials requires a minimum of 80 additional cases.
Sources: en.wikipedia.org
NMN stands for nicotinamide mononucleotide. It is a nucleotide composed of nicotinamide, ribose, and phosphate. In cells, it is an intermediate in NAD+ biosynthesis.
No, NMN and NAD+ are different molecules. NMN is a precursor that cells can convert into NAD+ through enzymatic steps. NAD+ is a larger dinucleotide that serves as a coenzyme in many reactions.
Nicotinamide riboside, or NR, is another NAD+ precursor but has a different structure. NR lacks the phosphate group present in NMN. Both are studied for their roles in NAD+ metabolism, yet they enter cellular pathways in different ways.
Liquid chromatography coupled with tandem mass spectrometry is widely used because it can separate NMN from related nucleotides and quantify low concentrations. Stable isotope-labeled internal standards help correct for matrix effects and recovery losses. Ultraviolet detection alone is less specific for complex biological matrices.